NCT04428567

Brief Summary

A pilot trial to determine the feasibility of treadmill training with dual training in patients with Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 30, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 1, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 11, 2020

Completed
Last Updated

October 28, 2021

Status Verified

October 1, 2021

Enrollment Period

8 months

First QC Date

October 1, 2019

Last Update Submit

October 20, 2021

Conditions

Keywords

Dual-taskfeasibilityFXTAStreadmill training

Outcome Measures

Primary Outcomes (3)

  • High levels of program attendance, and retention

    At each study visit the subjects attend and revisit were taken down throughout the entire intervention period in an attendance/retention log book.

    6 weeks

  • High levels of satisfaction

    At the end of the entire study a client satisfaction questionnaire was administered and interpreted based on a percent of satisfaction, ranging from zero to one hundred percent, on various satisfactory questions. Zero percent meaning highly unsatisfied and one hundred percent meaning highly satisfied.

    6 weeks

  • High levels of recruitment

    Research subjects were recruited using a recruitment flyer for the study and tracked by the number of willing participants.

    6 months

Secondary Outcomes (15)

  • Change in balance and mobility measured by Instrumented-SWAY (i-SWAY)

    6 weeks

  • Change in functional mobility measured by Instrumented-WALK (i-WALK)

    6 weeks

  • Change in balance and mobility measured by Mini-BEST balance scale

    6 weeks

  • Change in patient reported confidence in balance measured by Activities-Specific Balance Confidence Scale (ABC)

    baseline, week 6, post-training month 1 & month 6

  • Change in cognitive function measured by the Montreal Cognitive ASsessment (MoCa)

    6 months

  • +10 more secondary outcomes

Study Arms (2)

Treadmill Exercise + Cognitive Training (Dual-Task)

EXPERIMENTAL

The Dual-Task group will be provided with treadmill training with added simultaneous cognitive training during treadmill exercise training.

Behavioral: Dual-Task Treadmill exercise + Cognitive Training

Control Group

NO INTERVENTION

The control group will be assessed as the intervention group at the same time intervals without the intervention.

Interventions

The dual-task regimen will include treadmill exercise of 5-10 min warm-up and cool-down, 30 minutes of running towards target heart rate, combined with respond demands with the addition of cognitive tasks. The level of duration and intensity of treadmill exercise will progressively increase over the duration of 6 weeks.

Treadmill Exercise + Cognitive Training (Dual-Task)

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A diagnosis of possible, probable or definite FXTAS
  • Able to stand and walk without support for 2 minutes

You may not qualify if:

  • Any neurologic or musculoskeletal problems
  • History of traumatic brain injury
  • Significant cardiopulmonary or cardiovascular disease
  • Dementia or other significant cognitive impairment
  • Unstable psychiatric disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kellogg Building 1625 W. Harrison St. Room 235

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Conditions

Fragile X Tremor Ataxia Syndrome

Interventions

Cognitive Training

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Joan A O'Keefe, PhD, PT

    Rush University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The subjects will be randomly assigned to 2 groups: 1) treadmill training group with a cognitive task (Intervention group) 2) Control group. The entire intervention period is 6 weeks in both groups, with interventional training occurring 3 days per week for approximately 45 minutes per session. Evaluations will take place at baseline, 3 weeks, at the end of 6 weeks, and 1 month and 6 months after the intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2019

First Posted

June 11, 2020

Study Start

July 30, 2019

Primary Completion

March 30, 2020

Study Completion

March 30, 2020

Last Updated

October 28, 2021

Record last verified: 2021-10

Locations